Views | |
---|---|
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population | 76 |
grudnia 2022 | stycznia 2023 | lutego 2023 | marca 2023 | kwietnia 2023 | maja 2023 | czerwca 2023 | |
---|---|---|---|---|---|---|---|
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
Views | |
---|---|
korkosz_et-al_efficacy_andsafety_of_golimumab_as_add-on_therapy_2018.pdf | 99 |
korkosz_et-al_efficacy_andsafety_of_golimumab_as_add-on_therapy_2018.odt | 5 |
Views | |
---|---|
United States | 51 |
Poland | 4 |
Germany | 3 |
Vietnam | 3 |
Bulgaria | 1 |
Canada | 1 |
Ireland | 1 |
Malaysia | 1 |
Netherlands | 1 |
Views | |
---|---|
Ashburn | 29 |
Chandler | 6 |
Fairfield | 4 |
Hanoi | 3 |
Woodbridge | 3 |
Chorzelow | 2 |
Des Moines | 2 |
Seattle | 2 |
Burgas | 1 |
Cambridge | 1 |